Understanding the genetic origins of disease variation
Researchers, using high-resolution mapping and mathematical modelling, have found mechanisms controlling mutation-driven diseases.
List view / Grid view
Researchers, using high-resolution mapping and mathematical modelling, have found mechanisms controlling mutation-driven diseases.
Findings about how erythrocytes interact with brain capillaries offers new potential treatments for brain microhaemorrhages.
An advanced computational model enables scientists to study how cancer cells navigate through blood vessels.
New findings about how RBM10 inhibits lung cancer growth offers potential for an anti-cancer drug and more personalised treatment.
Studying pancreatic ductal adenocarcinoma tumours, researchers discovered 25 antibodies that responded to antigens.
A technique that can sort millions of CRISPR-edited cells based on their secretion patterns has been developed to treat autoimmune diseases.
A signalling mechanism for ventricular fibrillation involving the stress kinases p38γ and p38δ has been discovered.
In Alzheimer’s disease patients, irritability and anxiety is likely caused by neuroinflammation, which indicates new therapeutic pathways.
Combining cancerous and non-cancerous cell patterns, the AI model evaluates breast cancer outcomes better than expert pathologists.
Method to improve sterility assurance in biopharmaceutic manufacturing will lead to better patient outcomes.
Treating C. elegans with inhibitors of small or large mitochondrial ribosomes extended their median lifespan.
Researchers have completely decoded the human Y chromosome, which may result in more effective treatment for digestive disorders.
Findings of rare CRISPR-linked gene modules and a novel CRISPR-Cas system have promising implications for genomic therapeutics.
Novel findings about the tafazzin gene offers a potential new target and drug candidate for Barth syndrome.
Discovery about the DNA of leukaemia cells suggests promising target for gene therapy in paediatric oncology.